Minimally Invasive Holmium:YAG Laser Blepharoplasty
This study has been completed.
Information provided by (Responsible Party):
Montana Compton, University of California, Irvine
First received: February 11, 2009
Last updated: October 22, 2014
Last verified: October 2014
The purpose of this research study is to is to evaluate the safety and effectiveness of the FDA approved Holmium:YAG laser for reducing lower eyelid bags.
Lower Eyelid Entropion
||Endpoint Classification: Safety/Efficacy Study
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Treatment
||Minimally Invasive Holmium:YAG Laser Blepharoplasty
Primary Outcome Measures:
- reducing lower eyelid bags [ Time Frame: 6 months ] [ Designated as safety issue: Yes ]
| Study Start Date:
| Study Completion Date:
| Primary Completion Date:
||September 2014 (Final data collection date for primary outcome measure)
Other Name: laser
The researchers are interested in learning if the more precise Holmium:YAG laser can effectively tighten the orbital septum, a barrier of the orbit which holds fat in the bony orbit, while resulting in less unintentional surrounding damage and side effects.
|Ages Eligible for Study:
||30 Years and older
|Genders Eligible for Study:
|Accepts Healthy Volunteers:
- male/female 30 years and older
- have pronounced lower eyelid fat pads.
- based on medical problems.
- Previous surgery or trauma to lower eyelid or orbit.
- pregnant or lactating.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study.
To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below.
For general information, see Learn About Clinical Studies.
Please refer to this study by its ClinicalTrials.gov identifier: NCT00842764
|Orange, California, United States, 92868 |
||Brian J Wong, M.D,PhD
No publications provided
||Montana Compton, Administrative Nurse Research Coordinator Beckman Laser Institute, University of California, Irvine
History of Changes
|Other Study ID Numbers:
|Study First Received:
||February 11, 2009
||October 22, 2014
||United States: Institutional Review Board
Keywords provided by University of California, Irvine:
ClinicalTrials.gov processed this record on November 24, 2014